LNTH FY 2021 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$6B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$425M+25.3% YoY

Gross Profit

$188M44.1% margin

Operating Income

-$61M-14.3% margin

Net Income

-$71M-16.8% margin

EPS (Diluted)

$-1.06

Cash Flow

Operating Cash Flow

$54M

Free Cash Flow

$42M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$864M

Total Liabilities

$399M

Stockholders' Equity

$464M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$425M	$339M	+25.3%
Gross Profit	$188M	$139M	+35.3%
Operating Income	-$61M	-$4M	-1348.9%
Net Income	-$71M	-$13M	-429.1%